24 May 2013
Keywords: Bayer, Janssen, Portola, Xarelto, Antidote, Johnson & Johnson, PRT4445, Factor Xa inhibitors
Article | 06 February 2013
Germany’s Bayer (BAYN: DE) and Janssen Pharmaceuticals, a part of US health care giant Johnson & Johnson (NYSE: ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 February 2013
5 February 2013
23 May 2013
© 2013 thepharmaletter.com